The widespread use of classical antibiotics carries the risk of multi-resistance and also leads to unwanted side effects such as damage to the natural bacterial flora. In this subproject, highly selective RNA antibiotics are being developed as a novel approach for the targeted control of pathogenic bacteria. Antisense oligonucleotides are coupled to peptides that bind to specific surface structures of the bacteria, thus enabling the oligonucleotide to be introduced.